News & Views

  • Therapeutic Area
    • Cardiovascular
    • Endocrine & Metabolic
    • General Medicine
    • Neuroscience
    • Oncology & Hematology
    • Rare Disease
  • Phase
    • Bioanalytical Lab
    • Biosimilars
    • Phase I
    • Phase II-III
    • Phase IV & Real World Evidence
    • Pre IND
    • Regulatory Strategy
    • Rescue
  • Topics
    • Drug Development
    • People & Culture
    • Trial Design

Whitepaper First-in-Human Studies: IND or CTA

Case Study A United CRO-Biotech Partnership

Whitepaper Mastering Critical Binding Reagents in Immunoassays: The Key to Precision, Consistency, and Success

Whitepaper When the FDA knocks, answer with AME study results for clinical trial success

Fact Sheet Industry-Leading Psychedelic Clinical Development Services

Whitepaper The Utility of Drug Repurposing in Orphan Disease Research

Article Combatting a Silent Epidemic: Best Practices for Overcoming the Challenges of NAFLD Clinical Trials

Webinar Rare Disease Day 2023 Wrapped

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31

Blog

Transformational Relationships: How a Consultative Approach from a CRO Adds Value to Your Development Program

Read More

Before Clinical Trials: The Long Game of Rare Disease Research

Read More

Meet the Patient Advocate Panelists in Our Upcoming Webinar: Rare Disease Day 2023 Wrapped, What You Need to Take Away

Read More
See all

News

Worldwide Clinical Trials Expands Site Alliance Collaboration to Support Oncology Trials…

Read More

Worldwide Clinical Trials Partners with Every Cure to Accelerate Discovery of Treatments for Rare Disease…

Read More

Worldwide Clinical Trials Appoints Pete Duprat as Sr. Vice President, Commercial, Early Phase…

Read More
See all